Literature DB >> 22155435

Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: results from the CIBIS-ELD trial.

Goran Loncar1, Stephan von Haehling, Elvis Tahirovic, Simone Inkrot, Meinhard Mende, Nikola Sekularac, Mitja Lainscak, Svetlana Apostolovic, Biljana Putnikovic, Frank Edelmann, Rolf Wachter, Sinisa Dimkovic, Finn Waagstein, Götz Gelbrich, Hans-Dirk Düngen.   

Abstract

BACKGROUND: We sought to investigate the effect of beta-blocker (BB) up-titration on serum levels of NT-proBNP and copeptin in patients with heart failure (HF) with reduced (HFREF) or preserved ejection fraction (HFPEF).
METHODS: Serial measurements of NT-proBNP and copeptin were obtained after initiation of BB up-titration in 219 elderly patients with HFREF or HFPEF.
RESULTS: After initial increasing trend of NT-proBNP at 6 weeks in HFREF patients, there was a subsequent decrease at 12 weeks of BB treatment up-titration (p=0.003), while no difference was found compared to baseline levels. In contrast to NT-proBNP, there was a continuous decreasing trend of copeptin in HFREF patients (at 12 weeks: p=0.026). In HFPEF patients, NT-proBNP significantly decreased (p=0.043) compared to copeptin after 12 weeks of BB up-titration.
CONCLUSIONS: After 12 weeks of BB optimization copeptin might reflect successful up-titration faster than NT-proBNP in HFREF, while the opposite was found in patients with HFPEF.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155435     DOI: 10.1016/j.clinbiochem.2011.11.010

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

Review 1.  Heart failure management in the elderly - a public health challenge.

Authors:  Natasa Cvetinovic; Goran Loncar; Jerneja Farkas
Journal:  Wien Klin Wochenschr       Date:  2016-11-29       Impact factor: 1.704

2.  Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials.

Authors:  Frank Kramer; Javed Butler; Sanjiv J Shah; Christian Jung; Savina Nodari; Stephan Rosenkranz; Michele Senni; Luke Bamber; Stephan Cichos; Chrysanthi Dori; Toeresin Karakoyun; Gabriele Jenny Köhler; Kinjal Patel; Paolo Piraino; Thomas Viethen; Praneeth Chennuru; Ayse Paydar; Jason Sims; Richard Clark; Rob van Lummel; Alexandra Müller; Chad Gwaltney; Salko Smajlovic; Hans-Dirk Düngen; Wilfried Dinh
Journal:  Digit Biomark       Date:  2020-06-30

Review 3.  Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases.

Authors:  Danni Mu; Jin Cheng; Ling Qiu; Xinqi Cheng
Journal:  Front Cardiovasc Med       Date:  2022-07-04

Review 4.  Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need?

Authors:  Brian Kerr; Rebabonye B Pharithi; Matthew Barrett; Carmel Halley; Joe Gallagher; Mark Ledwidge; Kenneth McDonald
Journal:  Int J Heart Fail       Date:  2021-02-25

Review 5.  Emerging biomarkers in heart failure and cardiac cachexia.

Authors:  Goran Loncar; Daniel Omersa; Natasa Cvetinovic; Aleksandra Arandjelovic; Mitja Lainscak
Journal:  Int J Mol Sci       Date:  2014-12-22       Impact factor: 5.923

6.  Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study.

Authors:  Camilla Hage; Lars H Lund; Erwan Donal; Jean-Claude Daubert; Cecilia Linde; Linda Mellbin
Journal:  Open Heart       Date:  2015-11-03

7.  Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.

Authors:  Hans-Dirk Düngen; Verena Tscholl; Danilo Obradovic; Sara Radenovic; Dragan Matic; Lindy Musial Bright; Elvis Tahirovic; Almuth Marx; Simone Inkrot; Djawid Hashemi; Jovan Veskovic; Svetlana Apostolovic; Stephan von Haehling; Wolfram Doehner; Natasa Cvetinovic; Mitja Lainscak; Burkert Pieske; Frank Edelmann; Tobias Trippel; Goran Loncar
Journal:  ESC Heart Fail       Date:  2018-02-24

8.  Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure.

Authors:  Julio A Chirinos; Mayank Sardana; Garrett Oldland; Bilal Ansari; Jonathan Lee; Anila Hussain; Anique Mustafa; Scott R Akers; Wen Wei; Edward G Lakatta; Olga V Fedorova
Journal:  ESC Heart Fail       Date:  2018-07-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.